Guangdong Second Provincial General Hospital
Clinical trials sponsored by Guangdong Second Provincial General Hospital, explained in plain language.
-
New drug duo aims to stop leukemia from coming back
Disease control ENROLLING_BY_INVITATIONThis study tests whether adding venetoclax to standard chemotherapy can better prevent acute myeloid leukemia (AML) from returning after initial remission. About 232 adults aged 18–65 who are in remission will receive either the standard chemo or the combo. The main goal is to se…
Phase: PHASE2, PHASE3 • Sponsor: Guangdong Second Provincial General Hospital • Aim: Disease control
Last updated May 26, 2026 10:51 UTC
-
New hope for rare leukemia: Triple-Drug combo shows promise in early trial
Disease control ENROLLING_BY_INVITATIONThis study tests a three-drug combination (homoharringtonine, venetoclax, and azacitidine) in 40 adults newly diagnosed with a rare, aggressive leukemia called mixed-phenotype acute leukemia (MPAL). The goal is to see if this treatment can safely achieve complete remission. Parti…
Phase: PHASE2 • Sponsor: Guangdong Second Provincial General Hospital • Aim: Disease control
Last updated May 20, 2026 11:56 UTC